PDCD1 and melanoma: Jiao et al. showed that treatment of Cloudman S91 melanoma with an anti-melanin antibody (h8C3) labeled with alpha-emitting 213Bi in combination with anti-PD-1 led to tumor regression and improved overall survival over ICI monotherapy [62].